Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
In a double-blind study with a placebo group, chronic insomniac patients administered with a DSIP analogue experienced a reduction in sleep latency by an average of 22 minutes, suggesting its potential as a therapeutic agent for severe chronic insomnia patients (Anderer & Saletu, 1991)
As experts point out, a growing number of patients diagnosed with dry eye may actually experience chronic ocular pain, highlighting the need for therapies that address underlying pain mechanisms rather than surface symptoms
Every treatment plan starts with labs
Storage & handling Peptides require cold-chain handling to preserve integrity throughout your research timeline
US$ 20.01
US$ 26.65
US$ 29.88
